下面是原始网址 http://hkbuenews.hkbu.edu.hk/?t=press_release_details/349 在 2017-09-21 13:36:39 的快照。

360搜索与该网页作者无关,不对其内容负责。

Hong Kong Baptist University 香港浸会大学

Professor Lu Aiping (first row, centre), Dean of the School of Chinese Medicine, will serve as the Co-Director of the HKBU Branch of the State Key Laboratory of Chemo/Biosensing and Chemometrics of Hunan University, leading a team in conducting research together with Hunan University


中医药学院院长吕爱平教授 (前排中) 将出任「化学生物传感与计量学国家重点实验室(湖南大学)香港浸会大学分室」主任,率领其团队与湖南大学共同开展研究

Date: 28 Oct 2013 (Monday)

Archive

HKBU joins with Hunan University to establish Hong Kong branch of State Key Laboratory of Chemo/Biosensing and Chemometrics

浸大与湖南大学签署合作协议  在港成立化学生物传感与计量学国家重点实验室分室

HKBU joins with Hunan University to establish Hong Kong branch of State Key Laboratory of Chemo/Biosensing and Chemometrics

Hong Kong Baptist University (HKBU) has recently entered into an agreement with Hunan University to set up the HKBU Branch of the State Key Laboratory of Chemo/Biosensing and Chemometrics (CBC State Key Lab) of Hunan University, which will be the Hong Kong branch of the CBC State Key Lab. The two institutions will work together at the HKBU Branch to conduct research in molecular, biomedical and translational sciences, especially in the fields of systems biology and drug discovery in Chinese medicine.

The HKBU Branch will be led by an academic committee comprising Professor Albert Chan, President and Vice-Chancellor of HKBU, Professor Zhang Yugui, Director of the Academic Committee of the CBC State Key Lab, and other renowned experts from China and overseas. Professor Lu Aiping, Dean of the School of Chinese Medicine (SCM), HKBU, and Professor Tan Weihong, Director of the CBC State Key Lab, will serve as the Co-Directors of the HKBU Branch. Researchers of the Branch will come from SCM, the Institute for Advancing Translational Medicine in Bone & Joint Diseases (a joint initiative of SCM and the Faculty of Science, HKBU), and other researchers from HKBU in relevant disciplines as well as from the CBC State Key Lab.

Pursuant to the agreement, HKBU and Hunan University will collaborate at the HKBU Branch to conduct research in molecular, biomedical and translational sciences, especially in the fields of systems biology and drug discovery in Chinese medicine. The HKBU Branch aims to discover novel therapeutic drugs with Chinese traditional characteristics from herbs, to establish a platform for developing targeted drugs (combinatory drugs) with efficiency and safety in treating challengeable bone and joint diseases, and cancer and inflammation diseases by modifying natural small molecules using chemical biology (e.g. aptamer technology), and to advance personalised medicine through research in systems biology in Chinese medicine. Furthermore, the HKBU Branch will nurture experts in translational medicine and create an integrative platform for clinical medicine, basic research and fostering talent.

Professor Lu Aiping believes that through the collaboration of the two universities on research in molecular, biomedical and translational sciences, the HKBU Branch will be able to produce groundbreaking results that bring health benefits.

~ END ~


香港浸会大学最近与湖南大学签署合作协议,成立「化学生物传感与计量学国家重点实验室(湖南大学)香港浸会大学分室」(以下简称浸大分室),成为该国家重点实验室的香港分室,双方日后将共同开展分子科学、生物医学与转化科学的研究,特别是在中医药系统生物学与创新药物等方面的研究。

浸大校长陈新滋教授和湖南大学化学生物传感与计量学国家重点实验室学术委员会主任张玉奎教授,将与国内外著名专家组成香港分室学术委员会领导香港分室的发展;浸大中医药学院院长吕爱平教授和化学生物传感与计量学国家重点实验室主任谭蔚泓教授将共同担任香港分室主任。浸大分室成员包括浸大中医药学院、浸大骨与关节疾病转化医学研究所(中医药学院与理学院共同建设)、浸大相关学科的科研人员,以及化学生物传感与计量学国家重点实验室的科研人员。

浸大与湖南大学将在优势互补、资源共享的原则下,在浸大分室共同开展分子科学、生物医学与转化科学的研究,特别是在中医药系统生物学与创新药物等方面的研究。浸大分室期望利用中草药开发富有中国特色的创新药物研究,建立基于化学生物学技术(如核酸适配子技术)修饰的具精确靶向特徵的高效、安全天然小分子药物及组合药物开发平台,应用于存在临床挑战的骨与关节疾病、癌症与炎症性疾病的治疗上,并透过中医药系统生物学研究,发展「个体化医学」体系。此外,浸大分室亦将培养转化医学人才,建设临床、基础研究与人才一体化的平台。

吕爱平教授相信,透过两校进行的分子科学、生物医学与转化医学等研究,浸大分室能够在中医药研究领域取得突破性的成果,促进人类健康。

~ 完 ~
Press Contacts 传媒联络:

Connie Ko

School of Chinese Medicine

3411 2132

高洁媚

中医药学院

3411 2132

Jasmine Lau

Communication and Public Relations Office

3411 7828

刘子莹

传讯公关处

3411 7828